Vikram Deep Monga (Vikramdeep Monga)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

RSC medicinal chemistry

Journal of biomolecular structure & dynamics

Archiv der Pharmazie

Chemical biology & drug design

ISF College of Pharmacy

National Institute of Pharmaceutical Education and Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

ISF College of Pharmacy Nov 16 2017

India

Professor :: Pharmaceutical Chemistry

Rajendar Institute of Technology and Sciences Feb 06 2012 - Aug 24 2017

India

Professor :: Pharmaceutical Chemistry

Adesh Institute of Pharmacy and Biomedical Sciences May 16 2011 - Feb 04 2012

India

Associate Professor :: Pharmaceutical Sciences

ISF College of Pharmacy Aug 04 2009 - May 14 2011

India

Associate Professor :: Pharmaceutical Chemistry

Midwestern University - Chicago College of Pharmacy Aug 14 2008 - Jul 31 2009

United States

Postdoctoral Research Associate :: Chicago College of Pharmacy

Dr. Reddy's Laboratory Jan 29 2003 - Jul 31 2003

India

Trainee Chemist :: Research and development

Education History

National Institute of Pharmaceutical Education and Research Aug 01 2003 - Nov 29 2007

India

PHD :: Medicinal Chemsitry

Publications

Gurpreet Singh, Rajveer Singh, Vikram Deep Monga, Sidharth Mehan
Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, in vitro and in vivo anti-diabetic evaluation. RSC medicinal chemistry 15 (8) (2024)
Rakesh Khator, Vikram Deep Monga
Recent advances in the synthesis and medicinal perspective of pyrazole-based α-amylase inhibitors as antidiabetic agents. Future medicinal chemistry (2024)
Gurpreet Singh, Rajveer Singh, Vikram Deep Monga, Sidharth Mehan
Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, in vitro and in vivo anti-diabetic evaluation. RSC medicinal chemistry 15 (8) (2024)
Kulkarni Swanand Sanjay, Yogesh Singh, Avadh Biharee, Neha Bhatia, Vikram Deep Monga, Suresh Thareja
Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors. Journal of biomolecular structure & dynamics (2023)
Kulkarni Swanand Sanjay, Yogesh Singh, Avadh Biharee, Neha Bhatia, Vikram Deep Monga, Suresh Thareja
Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors. Journal of biomolecular structure & dynamics (2023)
Abhishek Chaurasyia, Pooja Chawla, Vikram Deep Monga, Gurpreet Singh
Rhodanine derivatives: An insight into the synthetic and medicinal perspectives as antimicrobial and antiviral agents. Chemical biology & drug design (2022)
Kumari Kajal, Gurpreet Singh, Tathagata Pradhan, Deendyal Bhurta, Vikram Deep Monga
The medicinal perspective of 2,4-thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review. Archiv der Pharmazie 355 (9) (2022)
Divya Chauhan, Ginson George, S N C Sridhar, Rohit Bhatia, Atish T Paul, Vikram Deep Monga
Design, synthesis, biological evaluation, and molecular modeling studies of rhodanine derivatives as pancreatic lipase inhibitors. Archiv der Pharmazie 352 (10) (2019)

Vikram Deep Monga.css-eqlu8i{font-size:small;padding-left:4px;} (Vikramdeep Monga)

Publication Activity (10 Years)

Top Topics

Top Venues

Vikram Deep Monga (Vikramdeep Monga)